Niobium in investor focus as Woomera raises $1.7m
ASX niobium hunters in Brazil rise today as Woomera secures an earn-in for its Gobi desert copper play in Mongolia.
Stockhead
Local stocks take courage on Monday, ASX ends 0.5pc higher
Aussie stocks have closed higher on Monday as IT and retail stocks added strength to sentiment.
Results bolster Tiros titanium and rare earths
Resouro’s latest results confirm the global-scale potential of its Tiros titanium project with assays up to 25% titanium and 11,000ppm rare earths.
Investors pile in on AusQuest
Additional maiden drilling results have confirmed Congallo as a significant, new greenfields porphyry discovery.
More Stories
SPR targets more gold for Dalgaranga restart
Spartan is looking to update resource confidence and add more ounces at the Dalgaranga gold project in WA.
Opthea could triple if phase III succeeds: Canaccord
Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as $3 if a key trial succeeds.
ASX biotechs hitting critical trial stage
Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory approval.
Canterbury jumps on copper discovery
Drilling at Alma Metals and Canterbury Resources’ Briggs asset in QLD uncovered near surface, high-grade copper and molybdenum mineralisation.
ASX hits record; Karoon jumps 8pc on buyback
ASX hits record high on rate cut hopes, energy stocks up as Karoon rallies and SoftBank eyes $25bn stake in OpenAI.
WYX places focus on bauxite
Western Yilgarn starts resource estimation work to confirm Julimar West as an advanced, strategically located bauxite project.
Tony’s Takeaway: Replicating rewards
Tony Locantro looks at a couple of ASX-listers showing some similarity upside when compared to much larger companies.
Airtasker posts another quarter of positive free cash flow
Airtasker has grown its positive free cash flow to $500,000 in Q2 FY25 with operating cash flow of $1m, up 40.0% on pcp.
Milestones hit by ASX health stocks
We run the ruler over ASX health stock quarterlies, with Bioxyne achieving record Q2 FY25 trading revenue.
ASX up as Fed stalls; Alibaba rattles Nvidia
ASX rises despite Wall Street dip, Alibaba’s AI shakes Nvidia, Lovisa hit with class action and IGO posts quarterly earnings loss.
Original URL: https://www.themercury.com.au/business/stockhead/page/15